SIMALTO is designed to reveal what stakeholders value most when they have to balance real-world demands alongside cost. Rather than rating each feature in isolation, respondents are asked to make choices, showing what they are prepared to prioritise and what they are willing to give up.

 We recently ran an internal knowledge-sharing session on endpoints, something we address every day in our post market survey work. We took a step back to define their critical role in protocol and survey design, and how these feed into medical device evaluations and regulations.

At Purdie Pascoe, the best partnerships are the ones that make a real difference to how we work day-to-day, and Metaforms is a strong example of that. It is an AI-assisted platform that supports survey programming, helping turn complex questionnaires into live surveys with less manual effort. One project type that used to take about a week of programming now takes two to three days. For our team, that creates more space to respond when clients need updates with a quick turnaround.

Changing stakeholder perceptions requires more than understanding sentiment – it requires a clear, credible positioning strategy built on real-world feedback. Through a three-phase Delphi research programme, we helped our client refine, test and validate communications in a market where healthcare decision-makers were increasingly sceptical and under-informed.

As we reach the midpoint of 2026, a clear picture is emerging from the conversations we've been having across the MedTech industry. While the topics may seem different on the surface, many are converging around a broader shift in how organisations think about evidence, insight, and the journey from innovation to real-world adoption. Rather than a set of trends or predictions, these are recurring themes we're seeing in practice and believe will continue to shape decision-making across the industry.

This infographic outlines how post‑market surveys such as PMCF and PMPF help generate real‑world data for medical devices, aligned with evolving regulatory expectations. It also highlights when these approaches are most effective across the device lifecycle. Download the full infographic to learn more.

DeviceTalks Boston 2026 brought together MedTech leaders, innovators, and investors to discuss the realities shaping medical device and technology development today. Kristy Beede, Research Director, and Nicole Levin, Associate Director, attended the conference, where the conversations reflected a sector that is becoming more connected, more data-driven, and increasingly focused on scalable, real‑world impact.

Many MedTech companies are rethinking the house of brands model as portfolios become more complex through platforms, digital ecosystems, and long-term partnerships. A stronger masterbrand can help scale trust across the portfolio, simplify complexity, and support adoption of new technologies and services.

At Purdie Pascoe, we believe strong teams are built through shared experiences as well as everyday work. Our recent US team-building event in Orlando marked two years of our US office and reflected the progress, trust and momentum our close‑knit team has built together.

Webcast now available, featuring expert presenters Edward Nobrega, Principal Clinical Evaluation Scientist at Boston Scientific, Breda Kearney, Clinical Regulatory Lead at BSI, and Marcus Torr, Head of Post Market Surveys at Purdie Pascoe.

This article explores the role of post-market RWD/RWE in establishing sufficient clinical evidence for legacy devices transitioning to the MDR. It outlines key data sources, explains how off-label data can be captured and used, shares Notified Body perspectives and case study examples, and considers how post-market surveys can generate high-quality RWD. It concludes with practical guidance on integrating these data into an ongoing clinical evidence strategy.

Attending Quirk’s London, Paolo Gambetti and Michael Butler highlighted a shift in the AI narrative, with less emphasis on excitement and more on real-world value, responsibility and impact.

We are delighted to be attending DeviceTalks Boston from 27–28 May 2026. Kristy Beede, Research Director, and Nicole Levin, Associate Director, will be representing Purdie Pascoe at the event.

With 2026 marking the Regulatory Affairs Professionals Society’s 50th anniversary, the atmosphere felt especially energised. Between packed auditoriums, poster sessions, and many conversations, one thing became increasingly clear: post-market evidence generation is entering a far more mature and strategically important phase.

We are thrilled to announce that Marcus Torr, Head of Post Market Surveys at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for a second year in a row. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

In this webcast, our Precision Medicine and Diagnostics experts explore why true differentiation is often overlooked in real-world practice, and what diagnostic companies can do to ensure their tests and portfolios are clearly understood, valued and adopted.

The countdown is on for the 2026 Annual Meeting of the American Society of Clinical Oncology, taking place May 29 – June 2 in Chicago. Purdie Pascoe’s Precision Medicine and Diagnostics experts Marianne Fillion and Vanessa Slade will be attending and are looking forward to connecting with delegates at one of the world’s leading oncology events.

 Behind every great research project is a system quietly keeping thousands of data points accurate, scalable, and insight ready. In this article, our Programming & Analytics experts explore how automation and innovation are transforming large-scale market research, freeing researchers to focus on what matters most: delivering meaningful insight.

After attending the Society of American Gastrointestinal and Endoscopic Surgeons Conference up the road in sunny Tampa, FL, it was easy to see why this year’s theme, connect to purpose, was so fitting. Across lectures, panels, posters, and exhibits, a consistent narrative emerged: surgeons, KOLs, engineers, and medical device manufacturers are deeply aligned in a shared mission to improve patient outcomes and elevate provider experience.

After attending the American College of Cardiology (ACC) Conference 2026, Molly Hines and Supreet Kaur reflected on their key takeaways from the event. At ACC, much of the discussion was shaped by how artificial intelligence is increasingly being embedded into clinical practice, workflows, and healthcare systems.